Skip to main content
. Author manuscript; available in PMC: 2024 Mar 18.
Published in final edited form as: J Vasc Surg. 2020 May 19;73(2):608–625. doi: 10.1016/j.jvs.2020.04.498

Table 5.

Associations of clinical characteristics with change in maximal treadmill walking time among participants randomized to exercise and control, respectively (continued)

N Baseline maximal treadmill walking time, mean (STD) 6-month maximal treadmill walking time, mean (STD) Within group change in maximal treadmill walking time, mean (95% CI) Between group change in maximal treadmill walking time, mean (95% CI) P value
Lower extremity revascularization
Participants randomized to exercise
No 96 7.30 (4.73) 11.88 (5.71) 4.58 (3.73, 5.43) Reference 0.6802
Yes 43 6.74 (4.57) 11.00 (5.07) 4.26 (2.98, 5.53) −0.32 (−1.85, 1.21)
Participants randomized to control
No 97 8.05 (4.13) 8.70 (4.30) 0.65 (0.05, 1.24) Reference 0.6607
Yes 40 6.09 (2.67) 6.49 (3.80) 0.40 (−0.53, 1.33) −0.25 (−1.35, 0.86)
Baseline six-minute walk
Participants randomized to exercise
≤ 333.8 meters 73 5.18 (3.01) 9.34 (4.09) 4.16 (3.19, 5.14) Reference 0.3518
> 333.8 meters 66 9.28 (5.22) 14.11 (5.83) 4.83 (3.80, 5.86) 0.67 (−0.75, 2.09)
Participants randomized to control
≤ 333.8 meters 62 5.65 (2.83) 5.78 (3.16) 0.13 (−0.61, 0.87) Reference 0.1094
> 333.8 meters 75 8.99 (3.95) 9.94 (4.16) 0.94 (0.27, 1.62) 0.81 (−0.19, 1.81)
Baseline maximal treadmill walking time
Participants randomized to exercise
≤6.30 minutes 75 3.92 (1.46) 9.50 (4.67) 5.58 (4.66, 6.51) Reference 0.0007
> 6.30 minutes 64 10.89 (4.32) 14.07 (5.44) 3.19 (2.18, 4.19) −2.40 (−3.76, −1.03)
Participants randomized to control
≤6.30 minutes 59 4.17 (1.39) 5.47 (3.27) 1.30 (0.55, 2.05) Reference 0.0120
> 6.30 minutes 78 9.98 (3.18) 10.01 (3.89) 0.03 (−0.62, 0.68) −1.28 (−2.27, −0.28)